Symbio is thrilled to announce and share the recent press release from Jasper Therapeutics. We are incredibly proud to have been the CRO partner for this successful study. This achievement marks a significant milestone in our collaboration and commitment to advancing innovative therapies for the treatment of Urticaria and other mast cell-mediated diseases. Read full press release, “Jasper Therapeutics Reports Positive Data from BEACON Study of Briquilimab in Chronic Spontaneous Urticaria”.
January 13, 2025, New York, NY and Munster, Germany: Symbio, the global specialist therapeutic clinical research organization, is pleased to announce two key leadership appointments.
Shanna Smith is appointed Chief Commercial Officer. Shanna has a 16-year tenure with Symbio and brings an extensive background in crafting customer solutions in both clinical operations and commercial functions. She has played a pivotal role in driving Symbio’s growth and commitment to quality, building outstanding relationships with clients and investigators, and expanding Symbio’s global presence.
Patrick Ronan is appointed to the Board of Directors of Symbio. Patrick currently serves as an Operating Partner at ARCHIMED, a global investment firm focused on the healthcare industries. He is the former CEO of two life sciences firms, Validant (now Eliquent Life Sciences) and Greenleaf Health, which he founded in 2007. Prior to this, Patrick served as VP Regulatory Policy & External Affairs at Novartis and before that as Chief of Staff at the U.S. Food and Drug Administration (FDA), an executive role where he led the Agency on strategic, operational, and regulatory policy matters.
In a joint statement, Alan Morgan, Chief Executive, and Nick Thornton, Chairman said, “The high caliber of these appointments reflects Symbio’s commitment to bringing the highest levels of expertise to our clients’ development programs. We congratulate Shanna and Patrick and wish them much success and enjoyment in their new roles.”
Press queries contact:
Rose Panico, Symbio Director of Global Marketing
Office: +1-631-474-8531
Mobile: +1-516-994-6683
rose.panico@symbioresearch.com
symbioresearch.com
Symbio is a global specialist therapeutic CRO with exceptional expertise in Dermatology, Aesthetics, Wound Care, Ophthalmology, Inflammation, and Gastroenterology. The business operates across the USA and Europe, with additional expertise in Latin America, and Asia.
Be sure to save the date and join Symbio at EADV Congress – Europe’s largest international meeting focused on dermatology and venereology, providing a platform for researchers, clinicians, and industry professionals to exchange knowledge, network, and present their latest research findings.
Paris, France
September 17 to 20, 2025
The Symbio team was thrilled to be exhibiting at the RAI in Amsterdam for the European Academy of Dermatology & Venereology (EADV) conference from September 25 to 28, 2024.
This year’s conference featured over 650 speakers from 50+ countries and conducted 18+ sessions which drew an audience of more than 17,000 delegates worldwide! The exhibit hall provided opportunities for attendees to explore the latest technologies, treatments and products in the dermatology and venereology fields.
Even more exciting was the opportunity for Symbio to exhibit our new, fresh-looking booth and company branding.
Our Business Development team was thrilled to meet with current and prospective clients as well as many incredible key industry professionals.
EADV Congress Happy Hour – House of Bols
Our special clients were invited to join us at our EADV Congress Happy Hour held on September 27 at The House of Bols in Amsterdam. It was a vibrant and delightful evening filled with socializing, handcrafted cocktails and a sumptuous Indonesian buffet enjoyed by all. Our guests also had the opportunity to engage in an intriguing cocktail workshop where they were able to master the craft of mixing delectable cocktails under the guidance of a skilled bartender.
The Symbio team was thrilled to attend the Medical Aesthetic Injectable Summit in Marbella, Spain, October 4-5.
This first-ever event was dedicated to the transformative advancements in the field of Medical Aesthetics and Injectables.
The congress brought together world-leading professionals through academia, business, and networking. Also in attendance were world-leading physicians, scientists, and top industry leaders.
We are very proud to have a poster presentation, written by our colleague, Shrutimita Pokhariyal.
Save the date for March 7 to 11 and get ready to launch your path to dermatologic expertise. Delve into an atmosphere of cutting-edge education led by dermatology experts and broaden your horizons by connecting with peers and industry leaders. See you at the show in March 2025!
As always, the AAD Annual Meeting was a resounding success. The Symbio team was able to meet with many clients and colleagues to discuss innovations in dermatology. It was great to see you all and we hope to connect again soon. Check out our photos and videos below.
You are currently viewing a placeholder content from YouTube. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
You are currently viewing a placeholder content from YouTube. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
It was good to connect with you at The EADV Congress in Berlin. We look forward to seeing you again soon and sharing ideas.
You need to load content from reCAPTCHA to submit the form. Please note that doing so will share data with third-party providers.
More Information
